Definitive Healthcare Corp. (NASDAQ:DH) Stock Has Average Target Price of $1.47 According to Brokerages

Key Points

• Analyst sentiment is cautious: Definitive Healthcare has a consensus “Reduce” rating, with three sell, six hold and one strong-buy recommendation. The average 12-month price target is $1.47.
• The stock opened at $1.17, within a 52-week range of $0.61 to $3.00; its market capitalization is about $124.9 million.
• In its latest reported quarter, the company earned $0.05 per share, beating estimates by $0.01, while revenue of $55.2 million fell short of consensus. It reported a negative net margin of 72.28%.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned a consensus rating of "Reduce" from the ten research firms that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $1.47.

A number of equities research analysts have recently weighed in on DH shares. Weiss Ratings reissued a "sell (e+)" rating on shares of Definitive Healthcare in a report on Monday, August 31st. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $1.00 target price on shares of Definitive Healthcare in a research note on Wednesday, August 12th. BTIG Research reissued a "neutral" rating on shares of Definitive Healthcare in a report on Friday, September 4th. Morgan Stanley decreased their target price on Definitive Healthcare from $2.50 to $1.50 and set an "equal weight" rating for the company in a report on Tuesday, August 11th. Finally, Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Sunday, September 13th.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock opened at $1.17 on Wednesday. The company has a 50 day moving average price of $1.00 and a 200 day moving average price of $1.08. The firm has a market capitalization of $124.90 million, a P/E ratio of -0.73, a PEG ratio of 13.94 and a beta of 1.40. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.81. Definitive Healthcare has a 52 week low of $0.61 and a 52 week high of $3.00.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Monday, August 10th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.01. The company had revenue of $55.20 million for the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. Sell-side analysts expect that Definitive Healthcare will post 0.06 EPS for the current year.

Institutional Trading of Definitive Healthcare

Several large investors have recently made changes to their positions in DH. Williams & Novak Wealth Management LLC lifted its position in Definitive Healthcare by 15.3% during the third quarter. Williams & Novak Wealth Management LLC now owns 90,610 shares of the company's stock valued at $82,000 after purchasing an additional 12,000 shares during the period. Squarepoint Ops LLC boosted its holdings in Definitive Healthcare by 46.5% in the second quarter. Squarepoint Ops LLC now owns 351,575 shares of the company's stock valued at $292,000 after purchasing an additional 111,634 shares during the last quarter. Corient Private Wealth LP acquired a new stake in Definitive Healthcare during the 2nd quarter worth about $378,000. Williams & Novak LLC grew its position in Definitive Healthcare by 155.8% during the 2nd quarter. Williams & Novak LLC now owns 78,610 shares of the company's stock worth $65,000 after purchasing an additional 47,880 shares during the period. Finally, Irenic Capital Management LP purchased a new position in shares of Definitive Healthcare during the 1st quarter valued at about $71,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp. NASDAQ: DH provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.